Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. - Wikidata - awgldk - TriplyDB

Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.

Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.

http://www.wikidata.org/entity/Q35165637

about

Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines.Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain.Potential role for mucosally active vaccines against pneumococcal pneumonia Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.Innate endogenous adjuvants prime to desirable immune responses via mucosal routes Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.Mouse models for the study of mucosal vaccination against otitis media.Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12.Mucosal vaccination against bacterial respiratory infections.Is intranasal vaccination a feasible solution for tuberculosis?Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines Interleukin-12 as an adjuvant for induction of protective antibody responses.Combination adjuvants: the next generation of adjuvants?Current adjuvants and new perspectives in vaccine formulation.Cytokines: the future of intranasal vaccine adjuvants.Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses.Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?An overview of adjuvant formulations and delivery systems.Recent advances in vaccine delivery.Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses.Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries.IL-12 as an adjuvant for the enhancement of protective humoral immunity.

P2860

Q30204865-96EDF985-4D83-466B-91BB-EA351B2E6246 Q33535951-9B585267-20C1-449B-8371-E7578E960CB1 Q33558303-18CA806E-AA39-4524-A79C-29256EF8629F Q33676505-F8CBC221-6504-41C0-8B9D-5913998309C7 Q33769426-0D3E0C16-DBA4-4FF1-B985-B7A169B8AB4C Q33792681-2CFA3B0E-1A77-42E5-9EFC-F18CF5FF4C8D Q33798317-D2E67596-362F-4DAA-BBEE-8DFEB822601C Q33999595-775B59FD-9F16-4EC7-9D49-D13856974AAD Q34309830-8E640B21-8DD7-4797-97D0-10C17251C887 Q34569275-3918DCB2-1516-4E1C-971A-465ECA3F6F93 Q35036583-3E68580D-C771-4FA1-B2BE-BCCACD4C4CAE Q35143128-CD2364AA-23D6-4DE9-9B4A-66B4B5596B0A Q35784151-457846DF-1DD7-42F5-A3F8-E70B4C151FFE Q35953762-3D833F80-AD20-4986-9B64-63989630E649 Q36097153-A27FAB11-25D5-4DF8-AA97-901359AC86F4 Q36116250-B797BA78-E170-4520-AFB6-917F1539BB35 Q36191199-BE6E7249-8F81-4ECE-B149-D304B5E334C5 Q36571911-1735782D-EDD6-428D-B3AF-B42B806A1B95 Q37093093-C1F0D440-0039-4E4F-A652-BE2D1108CFCA Q37272314-8C2F16FD-3872-47EF-8E16-BD05BFFE398B Q37290114-DC07EFFA-7C0E-42E7-ADF5-F2CB2499DA93 Q37316013-633A30CD-C104-4EE5-AA85-B14B1DE9B281 Q37590337-880132FF-7D00-4303-993B-AE4B63D98180 Q37774770-7AEAA9CD-2A3E-47AB-BF31-9EE2B45863CA Q37821483-13723A30-E375-44C6-9077-09B40E966862 Q37909424-4083F9D8-D1EC-4547-95E5-5D771C018BDB Q37914007-5D8F98D0-3113-438A-A008-7E9793A3CB5C Q37914449-9081D5D1-E1FD-4CE4-BA96-E82952E910DD Q38013202-03754284-F608-42EA-9607-F21AC32D2943 Q38126953-7452FF24-512D-4A0B-B9F7-25C8B2DF5FB4 Q38669255-82ECD27B-FA9C-4F2E-A6AB-73F5D257351F Q40277871-C35E9963-C111-4219-8741-48900B8EE2CA Q42116037-47587F4F-7DEF-4215-8A60-FFFBD9C67B05 Q43196580-8E355EDF-B487-468C-8495-D8645F71AEA2 Q46144154-369C9196-68C6-4A1B-8E80-004C5A1B26D4 Q47933660-C8E0D83F-3AAE-465E-9DF6-E13DA33D9786

P2860

Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.

http://www.wikidata.org/entity/Q35165637

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Increased protection against p ...... e vaccine plus interleukin-12.

@ast

Increased protection against p ...... e vaccine plus interleukin-12.

@en

type

label

Increased protection against p ...... e vaccine plus interleukin-12.

@ast

Increased protection against p ...... e vaccine plus interleukin-12.

@en

prefLabel

Increased protection against p ...... e vaccine plus interleukin-12.

@ast

Increased protection against p ...... e vaccine plus interleukin-12.

@en

P1433

Q35165637-D872ACD5-020B-4297-8207-B42A9BC38921

P1476

Q35165637-BFDDA0B9-5F99-4491-99F3-5E7FDDD88CC6

P2093

Q35165637-9E0170B1-1397-47D3-8C90-272468C0C149

Q35165637-AEBAE5C5-6EB7-48A3-A2E3-464DEB97A040

Q35165637-F7B457D8-1098-4FDC-BA04-77C9327CB016

P2860

Q35165637-1A0195ED-2F6D-4AD6-9473-A97E72713B51

Q35165637-1CB7F36D-0029-40B0-A2AA-C6D0A6E787E1

Q35165637-371893F4-63DE-4596-A2D6-C62D4B0A1E79

Q35165637-4AFB2BC4-AE34-439E-B971-E367BCB7BBB3

Q35165637-4E7605C1-E5FD-4D02-B7A6-A1527A9F9965

Q35165637-5D6E9627-0987-4F76-9066-E61D3F31DA3E

Q35165637-7523D46E-FFD3-4A57-958C-7365C68B677A

Q35165637-76384430-0097-4F71-9CA8-3C2AB4774A82

Q35165637-AB731993-B00B-4A1C-986D-9CB0C98EA944

Q35165637-B064F629-E9F7-4B9C-A790-7DDD150A3C8A

P304

Q35165637-A343CE2F-E851-46B6-A128-314C166CBF37

P31

Q35165637-9E27A4BB-9EF1-4F7A-AE5B-A4E838F19351

P356

Q35165637-415E8ACC-B652-4699-A5E9-998EABB564EC

P407

Q35165637-F3C3F131-A4A7-4E5C-B826-DD1603ACFC78

P433

Q35165637-700A390B-B523-4014-9052-6654EB7370F2

P478

Q35165637-B4D257CE-0B7F-455F-8168-9D4EBD7B19E2

P577

Q35165637-B962C1E1-393B-40E2-989F-2525F2634DDF

P5875

Q35165637-BC6A15BA-B1DC-4BBB-AE47-C123487991EA

P698

Q35165637-85B9CBD5-ADB0-4286-803F-06392E78118D

P932

Q35165637-193B6CE7-2E0E-4233-BCB3-B954BF70FB85

P356

IAI.71.8.4780-4788.2003

P1433

Infection and Immunity

P1476

Increased protection against p ...... e vaccine plus interleukin-12.

@en

P2093

David E Briles

http://www.w3.org/2001/XMLSchema#string

Dennis W Metzger

http://www.w3.org/2001/XMLSchema#string

Joyce M Lynch

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.

Structure and function of human and murine receptors for IgG.

Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogens.

Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.

P304

4780-4788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.71.8.4780-4788.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6518286

http://www.w3.org/2001/XMLSchema#string

P698

12874361

http://www.w3.org/2001/XMLSchema#string

P932

166054

http://www.w3.org/2001/XMLSchema#string